Gilead Sciences Inc (GILD)
- Exchange
- NASDAQ
- Symbol
- GILD
- Sector
- Life Sciences
- Industry
- Biological Products, (no Disgnostic Substances)
- Description
- Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
- Country
- USA
Stock price
At close: October 21, 2025
-
Open123.27
-
High124.61
-
Low121.92
-
Close124.08
-
Volume5,559,030
Financial ratios
Dec 31, 2024